Detalles de la búsqueda
1.
A randomised placebo-controlled, double-blind phase II study to explore the safety, efficacy, and pharmacokinetics of sonlicromanol in children with genetically confirmed mitochondrial disease and motor symptoms ("KHENERGYC").
BMC Neurol
; 22(1): 158, 2022 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-35477351
Resultados
1 -
1
de 1
1
Próxima >
>>